Dr. Chris Palmer

You know, what you're describing is kind of, in my mind, a really important next step. And the great news is that there are several research groups that I know of that are working on exactly that. One is a commercial company. I'm not going to name any names, but one is a commercial company that has a product of a series of biomarkers, blood biomarkers, that they believe are

You know, what you're describing is kind of, in my mind, a really important next step. And the great news is that there are several research groups that I know of that are working on exactly that. One is a commercial company. I'm not going to name any names, but one is a commercial company that has a product of a series of biomarkers, blood biomarkers, that they believe are

represent ultimately mitochondrial dysfunction, all of the different cellular pathways that can result in mitochondrial dysfunction and or can reflect mitochondrial dysfunction.

represent ultimately mitochondrial dysfunction, all of the different cellular pathways that can result in mitochondrial dysfunction and or can reflect mitochondrial dysfunction.

represent ultimately mitochondrial dysfunction, all of the different cellular pathways that can result in mitochondrial dysfunction and or can reflect mitochondrial dysfunction.

And they believe that their test might be able to predict the development of autism, that every child at age one should get this blood biomarker, and it will tell us who's at high risk of developing a neurodevelopmental disorder. The test itself doesn't tell us what's wrong. It just tells us something's wrong.

And they believe that their test might be able to predict the development of autism, that every child at age one should get this blood biomarker, and it will tell us who's at high risk of developing a neurodevelopmental disorder. The test itself doesn't tell us what's wrong. It just tells us something's wrong.

And they believe that their test might be able to predict the development of autism, that every child at age one should get this blood biomarker, and it will tell us who's at high risk of developing a neurodevelopmental disorder. The test itself doesn't tell us what's wrong. It just tells us something's wrong.

And then the clinicians need to go to work and try to figure out what is going on, what is causing this metabolic mitochondrial dysregulation so that we could potentially intervene. I've talked with one of the leading mitochondrial researchers really in the world. He's got a set of 20 biomarkers.

And then the clinicians need to go to work and try to figure out what is going on, what is causing this metabolic mitochondrial dysregulation so that we could potentially intervene. I've talked with one of the leading mitochondrial researchers really in the world. He's got a set of 20 biomarkers.

And then the clinicians need to go to work and try to figure out what is going on, what is causing this metabolic mitochondrial dysregulation so that we could potentially intervene. I've talked with one of the leading mitochondrial researchers really in the world. He's got a set of 20 biomarkers.

that he believes represent mitochondrial dysfunction broadly and then there's another research group um that is is actually narrowed it down to just five different biomarkers in men and five slightly different there's some overlap but slight differences in women

that he believes represent mitochondrial dysfunction broadly and then there's another research group um that is is actually narrowed it down to just five different biomarkers in men and five slightly different there's some overlap but slight differences in women

that he believes represent mitochondrial dysfunction broadly and then there's another research group um that is is actually narrowed it down to just five different biomarkers in men and five slightly different there's some overlap but slight differences in women

And those five biomarkers alone were able to distinguish people with chronic severe suicidal depression from healthy controls with over 90% sensitivity and specificity. Wow. So I think that is one of the directions we need to go is we need to establish tests with all of these groups.

And those five biomarkers alone were able to distinguish people with chronic severe suicidal depression from healthy controls with over 90% sensitivity and specificity. Wow. So I think that is one of the directions we need to go is we need to establish tests with all of these groups.

And those five biomarkers alone were able to distinguish people with chronic severe suicidal depression from healthy controls with over 90% sensitivity and specificity. Wow. So I think that is one of the directions we need to go is we need to establish tests with all of these groups.

I want to just state clearly and plainly because one of the common questions I get is what's the blood test I can get for my mitochondrial health? There isn't one. That's the answer. There is not one. There are... lots of different biomarkers that can suggest dysregulation of metabolism and mitochondrial function. And again, these three research groups are all working on it.

I want to just state clearly and plainly because one of the common questions I get is what's the blood test I can get for my mitochondrial health? There isn't one. That's the answer. There is not one. There are... lots of different biomarkers that can suggest dysregulation of metabolism and mitochondrial function. And again, these three research groups are all working on it.

I want to just state clearly and plainly because one of the common questions I get is what's the blood test I can get for my mitochondrial health? There isn't one. That's the answer. There is not one. There are... lots of different biomarkers that can suggest dysregulation of metabolism and mitochondrial function. And again, these three research groups are all working on it.